Gilead Sciences, Inc. 13D and 13G filings for HOOKIPA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-12-22 4:18 pm Purchase |
2023-12-20 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC GILD |
1,875,947 19.400% |
1,500,000![]() (+398.99%) |
Filing |
2023-02-14 2:06 pm Unchanged |
2022-03-24 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC GILD |
375,947 7.200% |
0 (Unchanged) |
Filing |
2022-02-17 2:43 pm Purchase |
2022-02-15 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC GILD |
375,947 12.900% |
166,667![]() (+79.64%) |
Filing |
2021-02-12 4:36 pm Purchase |
2020-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC GILD |
209,280 7.200% |
42,553![]() (+25.52%) |
Filing |